IL10 and inflammatory bowel disease: Therefore, the authors intend to evaluate the potential clinical use of the FOXP3 genetic variants and the serum levels of the IL-10 and TGF-β as surrogate diagnostic biomarkers of IBD susceptibility, and clinical and endoscopy activity.